MEHVESH AFRINA: Open Payments
NPI 1326215047 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,536 in 75 payments from 16 companies in 2025. Trend: 2023 $1,462 · 2024 $1,176 · 2025 $1,536
Food & beverage: $1,536
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 11 | $278 |
| Alkermes, Inc. | 12 | $166 |
| Janssen Pharmaceuticals, Inc | 7 | $129 |
| Lundbeck LLC | 5 | $126 |
| Collegium Pharmaceutical, Inc. | 7 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| Teva Pharmaceuticals USA, Inc. | 3 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $91 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Tris Pharma Inc | 3 | $65 |
Products named: Azstarys, REXULTI, LYBALVI, Jornay PM, TRINTELLIX, AUSTEDO XR, CAPLYTA, SPRAVATO.
Industry payments across TX — which companies pay providers there.
